Personal profile
Education/Academic qualification
Doctor of Medicine, Unversitat Erlange-Nurnberg (Germany)
1979
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Reinhold Munker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
22-HEM-19-MSD: A Phase 3 Randomized Clinical Study of MK-4280A (Coformulated Favezelimab [MK-4280] plus Pembrolizumab [MK-3475]) Versus Physician's Choice Chemotherapy in PD-(L)1-Refractory, Relapsed or Refractory Classical Hodgkin Lymphoma
Munker, R. (PI)
Merck Sharp & Dohme Corporation
1/23/23 → 11/2/26
Project: Research project
-
Investigating the Feasibility, Usability, and Efficacy of a Mobile App to Reduce Anxiety and Depression in Families of Critical Care Cancer Patients: A Quasi-Experimental Pilot Study
Faiola, A., Soroya, S., Munker, R., Hao, Z. & Lambert, J., Feb 2026, In: Healthcare (Switzerland). 14, 3, 353.Research output: Contribution to journal › Article › peer-review
Open Access -
The platelet transcriptome after stem cell transplantation
Lin, L. I., Whiteheart, S. W. & Munker, R., Apr 2026, In: Clinical and Translational Discovery. 6, 2, e70121.Research output: Contribution to journal › Letter › peer-review
Open Access -
Commentary: is trogocytosis relevant for chimeric antigen receptor-T cells?
Toolabi, B., Whiteheart, S. W. & Munker, R., Jun 1 2025, In: Oncologist. 30, 6, oyaf150.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
New developments in immunotherapy for SCLC
Dolkar, T., Gates, C., Hao, Z. & Munker, R., Jan 6 2025, In: Journal for ImmunoTherapy of Cancer. 13, 1, e009667.Research output: Contribution to journal › Review article › peer-review
Open Access11 Scopus citations -
Tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma: Efficacy and safety from the phase II PROSPECT study
Nayak, L., Grommes, C., Kallam, A., Peereboom, D. M., Ambady, P., Mendez, J. S., Aregawi, D. G., Sumrall, A. L., Omuro, A. M. P., Iwamoto, F., Dietrich, J., Umemura, Y., Munker, R., Chukwueke, U. N., Schaff, L., Prados, S., Takazawa, A., Aoi, A. & Batchelor, T., 2025, In: Journal of Clinical Oncology. 43, 16, 2019.Research output: Contribution to journal › Article › peer-review
1 Scopus citations